Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation
Conditions: Hematologic Cancer Interventions: Device: Photobiomodulation; Other: Usual care Sponsors: Universidad del Desarrollo; Agencia Nacional de Investigaci ón y Desarrollo; Clínica Dávila Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Patient-derived Stem Cell Models of Anorexia Nervosa
Conditions: Anorexia Nervosa Interventions: Other: observational Sponsors: Karolinska Institutet Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Collection of Ocular Surface Impressions Cytology of the Living Eye From Patients With Dry Eyes or Limbal Stem Cell Deficiency.
Conditions: Eye Diseases Interventions: Diagnostic Test: EYEPRIM Sponsors: Centre Hospitalier Universitaire de Saint Etienne; Laboratoire Biologie, Ing énierie et Imagerie de la Greffe de Cornée (BiiGC) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
HHV-6-specific T-cell Reconstitution Among Children and Adolescents After Allogeneic Stem.
Conditions: Allogeneic Stem Cell Transplantation Interventions: Other: Cell cultivation, Antigen testing Sponsors: Medical University of Graz Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation
Conditions: Graft Versus Host Disease; Hematologic Malignancy Interventions: Drug: Methotrexate; Drug: Post-Transplant Cyclophosphamide; Drug: Fludarabine; Drug: Cycophosphamide; Drug: Anti-Thymoglobulin; Radiation: total body irradiation; Other: hematopoietic stem cells; Other: Graft nuclear cells; Other: Donor Lymphocytes Injection; Drug: Clofarabine; Drug: Thiotepa; Drug: Busulfan; Drug: Fludarabine Sponsors: Nantes University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients
Conditions: Recurrent Oligodendroglioma; Progressive Oligodendroglioma Interventions: Biological: TTRNA-DC vaccines with GM-CSF; Biological: Autologous Hematopoietic Stem cells (HSCs); Biological: TTRNA-xALT; Drug: Td vaccine Sponsors: University of Florida; Oligo Nation, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation
Conditions: Very High Risk Acute Lymphoblastic Leukemia; CD19 CAR-T Therapy Interventions: Genetic: SNUH-CD19-CAR-T Sponsors: Seoul National University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia; Neutropenia; Anemia; Thrombocytopenia; Infections; Bleeding Interventions: Biological: umbilical cord derived mesenchymal stem cells exosomes (UCMSC-Exo) Sponsors: Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)
Conditions: Chronic Graft Versus Host Disease Interventions: Biological: Additional blood sample; Biological: cGVHD target tissue biopsy Sponsors: University Hospital, Bordeaux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT
Conditions: Moxibustion; Hematopoietic Stem Cell Transplantation; Hemorrhagic Cystitis; Treatment Interventions: Other: Moxibustion; Other: Symptomatic supportive treatment Sponsors: Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Effect of Different Frequencies of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD
Conditions: End Stage Liver DIsease Interventions: Biological: umbilical cord-mesenchmal stem cells Sponsors: General Hospital of Shenyang Military Region Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa Interventions: Biological: GMP compliant-BM-MSC derived sEVs Sponsors: Mahidol University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Upfront Related Donor Transplantation in Patients With Myelodisplatic Syndrome : a Phase 2 Trial
Conditions: Myelodysplastic Syndromes Interventions: Biological: Hematopoietic stem-cell transplantation Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
Conditions: Acute Myeloid Leukemia Interventions: Drug: Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;; Drug: Venetoclax (Venetoclax): 400mg on day 1 to day 7; oral administration;; Other: utologous stem cell transplantation (ASCT) /allogeneic hematopoietic stem cell transplantation (allo-HSCT). Sponsors: The First Affiliated Hospital with Nanjing Medical University; Huai ' an First People ' s Hospital; Yancheng First People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy of Stem Cells for Diabetic Foot Ulcer
Conditions: Diabetic Foot Ulcer Interventions: Drug: Allogeneic mesenchymal stem cells (MSCs) / Placebo Sponsors: Supergenics Life Science Sdn. Bhd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
